TP53 and neoplasm: The remainder of the tumor (60% of tumoral volume) displayed a p53-wild type immunophenotype, and were p16-mosaic positive, vimentin-positive, Napsin A-negative, estrogen receptor positive, and progesterone receptor-positive.